Sign in

East West Bancorp, Inc. EWBC

Price 130.6 USD
as of 2026-09-04
67/100
No view
Quality75
Growth68
Balance-sheet strength60
Valuation65
Momentum64
Income66

Composite 67/100; the shares have moved about 21% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Its least supportive area is Balance-sheet strength at 60 — still above average.

Case for

Quality ranks 75/100 — a moderate point in its favour. Growth ranks 68/100 — a moderate point in its favour. Income ranks 66/100 — a moderate point in its favour.

Case against

Its least supportive area is Balance-sheet strength at 60 — still above average.

What the company does East West Bancorp, Inc. (EWBC) is a Pasadena-based regional bank holding company operating East West Bank, offering personal and commercial banking, trade finance, wealth management, and digital banking services, with a focus on U.S.-Asia business connections.

Key financials EWBC reports ROE 16.6%, ROA 1.8%, and ROCE 7.0%. Net margins stand at 50.1% with revenue and EPS growth of 16.3% and 17.4%, respectively. The dividend yield is 2.1% with a payout ratio of 26.9%.

Stock health The stock shows strong momentum: +30.06% over 12 months, +16.31% over 6 months, and +5.65% over 3 months. The Sideravia score is 61.9, with Quality 67.3 and Income 74.2, indicating robust fundamentals and attractive valuation.

Price vs fair value EWBC trades at a PREMIUM of 12.30% versus our fair-value estimate of 114.83 and at a discount of 12.20% versus the 12-month analyst target of 146.88. - Trading at a premium to fair value despite strong fundamentals (Sideravia Overall 61.9). - Discount to analyst target reflects upside potential noted by 16 analysts (target 146.88). - Recent dividend-focused headlines may be supporting sentiment (24/7 Wall St., Jul 26-27).

Looking forward Forward P/E of 14.90 suggests moderate earnings expectations. Growth and momentum metrics remain positive, but valuation remains a key consideration given the premium to fair value.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.